Long-term outcomes of kidney donors

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 6, 2011, Pages 605-609

  Morgan, Benjamin R ^a   Ibrahim, Hassan N ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

health outcomes; kidney; living donor

Indexed keywords

AFRICAN AMERICAN; CHRONIC DISEASE; DIABETES MELLITUS; HIGH RISK POPULATION; HISPANIC; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY DONOR; KIDNEY FAILURE; LIFE EXPECTANCY; LIVING DONOR; LONG TERM CARE; MORBIDITY; OBESITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SAFETY; SURGICAL MORTALITY; SURVIVAL;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIVING DONORS; PREGNANCY; PREGNANCY OUTCOME; QUALITY OF LIFE; RISK FACTORS; TISSUE AND ORGAN HARVESTING; UNITED STATES;

EID: 80054758143     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834bd72b     Document Type: Review

References (30)

1. Merrill JP, Murray JE, Harrison JH, et al. Successful homotransplantation of the human kidney between identical twins. JAMA 1956; 160:277-282.
2. Mange K, Joffe M, Feldman H. Effect of the use or nonuse of long-term dialysis on the subsequent survival on renal transplant from living donors. N Engl J Med 2001; 344:726-731. (Pubitemid 32204990)
3. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333:333-336.
4. Segev D, Muzaale A, Caffo B, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303:2248-2249.
5. Johnson EM, Remucal MJ, Gillingham KJ, et al. Complications and risks of living donor nephrectomy. Transplantation 1997; 64:1124-1128. (Pubitemid 27467936)
6. Matas AJ, Bartlett ST, Leichtman AB, Delmonico FL Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant 2003; 3:830-834. (Pubitemid 36827904)
7. Friedman AL, Peters TG, Jones KW, et al. Fatal and nonfatal hemorrhagic complications of living kidney donation. Ann Surg 2006; 243:126-130. (Pubitemid 43054065)
8. Fehrman-Ekholm I, Norden G, Lennerling A. Incidence of end-stage renal disease among live kidney donors. Transplantation 2006; 82:1646-1648. (Pubitemid 46035644)
9. Okamoto M, Akioka K, Nobori S. Short- and long-term outcomes after kidney donation: analysis of 601 cases over a 35-year period at Japanese single center. Transplantation 2009; 87:419-423.
10. Ibrahim H, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360:459-469.
11. Fehrman-Ekholm I, Elinder C, Stenbeck M, et al. Kidney donors live longer. Transplantation 1997; 64:976-978. (Pubitemid 27446761)
12. Foley R, Ibrahim H. Long-term outcomes of kidney donors. Curr Opin Nephrol Hypertens 2010; 19:129-133.
13. Taler SJ, Gillespie B, Ibrahim H. Predictors of end stage renal disease in live kidney donors at three U.S. kidney transplant centers. Am J Transplant 2011; 11:156.
14. Gibney E, Parikh C, Garg A. Age, gender, race, and associations with kidney failure following living kidney donation. Transplantation Proc 2008; 40:1337-1340. (Pubitemid 351853169)
15. Lentine K, Schnitzler M, Xiao H, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363:724-732.
16. Young A, Storsley C, Garg AX. Health outcomes for living kidney donors with isolated medical abnormalities: a systematic review. Am J Transplant 2008; 8:1878-1890.
17. Tavakol M, Flavio V, Hamid H. Long term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol 2009; 4:1230-1238.
18. Nogueira J, Weir M, Jacobs S, et al. A study of renal outcomes in obese living kidney donors. Transplantation 2010; 90:993-999.
19. Heimbach J, Taler S, Prieto M, et al. Obesity in living kidney donors: clinical characteristics and outcomes in the era of laparoscopic donor nephrectomy. Am J Transplant 2005; 5:1057-1064. (Pubitemid 40571254)
20. Reese PP, Feldman HI, Asch DA, et al. Short-term outcomes for obese live kidney donors and their recipients. Transplantation 2009; 88:662-671.
21. Okamoto M, Suzuki T, Fujiki M, et al. The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center. Transplantation 2010; 89:1391-1395.
22. Dols LC, Kok NM, Roodnat JI. Living kidney donors: impact of age on longterm safety. Am J Transplant 2011; 11:737-742.
23. Reisaeter A, Roislien J, Henriksen T, et al. Pregnancy and birth after kidney donation. The Norwegian experience. Am J Transplant 2009; 9:820-824.
24. Vikse B, Irgens L, Leivestad T, et al. Preeclampsia and risk of end stage renal disease. N Engl J Med 2008; 359:800-809.
25. Ibrahim H, Akkina S, Leister E, et al. Pregnancy outcomes after kidney donation. Am J Transplant 2009; 9:825-834.
26. Mjoen G, Stavem K, Westlie L, Midvedt K. Quality of life in kidney donors. Am J Transplant 2011. [Epub ahead of print]
27. Johnson E, Anderson J, Jacobs C, et al. Long-term follow-up of living kidney donors: quality of life after donation. Transplantation 1999; 67:717-721. (Pubitemid 29161713)
28. Clemens K, Boudville N, Dew M. Long-term quality of life of living kidney donors: a multicenter cohort. Am J Transplant 2011; 11:463-469.
29. Ibrahim H, Kukla A, Cordner G, et al. Diabetes after kidney donation. Am J Transplant 2010; 10:331-337.
30. Parving H, Lehnert H, Brochner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001; 345:870-878.